Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.
Khodakarami A, Kashani MA, Nazer A, Kheshti AM, Rashidi B, Karpisheh V, Masjedi A, Abolhasani S, Izadi S, Bagherifar R, Hejazian SS, Mohammadi H, Movassaghpour A, Feizi AAH, Hojjat-Farsangi M, Jadidi-Niaragh F.
Khodakarami A, et al. Among authors: rashidi b.
Cell Commun Signal. 2023 Aug 1;21(1):188. doi: 10.1186/s12964-023-01213-1.
Cell Commun Signal. 2023.
PMID: 37528446
Free PMC article.